BCHE and Lewy body dementia: The use of cholinesterase inhibitors appears to be low compared to the general clinical situation (60% in the DLB + TH group, 34% in the DLB‐TH group); this is due to the data from the time of the first consultation at our hospital, when DLB had not yet been diagnosed (DLB would be diagnosed based on the test results at that time).